Use of Dexamethasone in Prevention of the Second Phase or a Biphasic Reaction of Anaphylaxis
Clinical trial NCT03523221 · RECRUITING
Trial details
- NCT number
- NCT03523221
- Sponsor
- Hamad Medical Corporation
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-15
- Primary completion
- 2024-12-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.